The Changing Landscape of European Healthcare Sector: Panel and Angel Pitch Event
Healthcare is one of the largest sectors of the UK economy and one of the most dynamic due to considerable research investment and the on-going NHS restructuring. There was more R&D performed in the pharmaceutical sector than any other, with expenditure in 2010 at £4.6 billion, representing 29% of all UK R&D spending. However, It is estimated that only 30-70% of patients respond positively to any particular drug. Even the best medicines are not equally effective in all patients. Recent advances in science, particularly in molecular biology and genomics, mean that it is sometimes possible to identify the underlying molecular mechanisms of disease (in particular their genetic causes) in patients. The Stratified Medicine (Personalized Medicine) Innovation Platform seeks to build on the UK’s strength within the global healthcare industries and put it at the centre of the next generation of medicine.
In December 2012 Prime Minister David Cameron said that the government's National Health Service (NHS) has earmarked £100 million, or about $160 million, to the effort. The money is part of a £600 million government healthcare investment announced for research in the coming years. The sequencing is expected to take 3 to 5 years.
Entrepreneurs selected to present:
Contact: el2332 (at) columbia.edu
Tuesday, 28 May 2013, 7:00 PM
55 Baker Street
Marylebone W1U 7EU
Closest tube: Baker Street, Marble Arch
Organized by Emmanuel Leonard (MS '07) together with the Wharton Club of London